Torok et al. [27]in OXTREC 023–04 clinical trial (median CD4 count of 41 cells/μL) compared cART within seven days of TB treatment initiation with eight weeks after in TB meningitis cases. This evidence concerns the gene CD4 and infectious meningitis.